Eli Lilly & Co
A pharmaceutical company whose medicines treat diabetes and obesity (Mounjaro, Zepbound, Trulicity, Jardiance), cancer (Verzenio, Cyramza), immunology conditions, and neurological diseases like migraine and Alzheimer's. Founded in 1876 in Indianapolis by Colonel Eli Lilly, a Civil War veteran and chemist, the firm started as a wholesale drug maker. Its founder opened the lab partly to fight the "snake oil" patent medicines of his day, vowing to sell only high-quality remedies recommended by physicians.
Sold 15.8K
Granted 39.63
Granted 49.61
Sold 2.5K
Granted 63.59
Granted 19.81
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Lilly Endowment IncFormer 10% Shareholder · 2 transactions | -0.3% | 91.88M | — | — | 15.8K |
| Fyrwald J ErikDirector · 4 transactions | +0.4% | 75.4K | 39.63 | — | — |
| Alvarez RalphDirector · 4 transactions | +0.4% | 56.5K | 49.61 | — | — |
| Yuffa IlyaEVP&Pres, LLY USA&Global Capab · 1 transaction | -7.7% | 29.8K | — | — | 2.5K |
| Luciano Juan RDirector · 4 transactions | +0.7% | 16.9K | 63.59 | — | — |
| Sulzberger GabrielleDirector · 4 transactions | +1% | 3.0K | 19.81 | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -18.3K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.